Most healthy people exhibit a decrease in systolic blood pressure (SBP) at night. a drop of <10% from mean daytime values, "non-dipping, " is associated with kidney disease and cardiovascular events. We hypothesized that non-dipping would predict all-cause mortality.
In most healthy individuals, there is a nocturnal decline in mean systolic blood pressure (SBP) of at least 10% from mean daytime values. 1 Patients lacking a normal nocturnal decline in blood pressure (BP) have been referred to as "non-dippers" while those with normal diurnal BP variation are termed "dippers. " 2 Nondipping has been associated with hypertension in the elderly, 3 obstructive sleep apnea, 4 types 1 and 2 diabetes mellitus, 5, 6 insulin resistance, 7 and chronic kidney disease, 8, 9 independent of mean 24-h SBP. Additionally, longitudinal studies have demonstrated that non-dipping is associated with target organ damage, including cardiovascular morbidity and mortality, 10, 11 the development and progression of renal disease, [12] [13] [14] and the development of cerebrovascular disease. 15 The mechanisms responsible for abnormal diurnal BP variation remain unclear, but probably involve an impairment in autonomic balance that leads to relative sympathetic overactivity at night. [16] [17] [18] [19] The association between non-dipping and all-cause mortality remains uncertain. Although one population-based study demonstrated that non-dipping is associated with an increased risk of cardiovascular death in Japanese patients, 20 there was no significant increase in non-cardiovascular death. It is worthwhile to note that the authors of this study used death-certificate data to ascertain the cause of death, and categorized mortality from renal failure and sudden death as non-cardiovascular. Additionally, these researchers did not provide data on renal function, which is associated both with impaired diurnal BP variation and with death, 13, 21, 22 and did not adjust for mean 24-h BP in their statistical models. The purpose of the current investigation was to examine the prognostic impact of diurnal BP variability on subsequent all-cause mortality.
METHODS

Study design.
We conducted a retrospective cohort study of outpatients referred to the Department of Hypertension and Nephrology at the Cleveland Clinic Foundation for ambulatory BP monitoring between November 1994 and December 2004. Consecutive patients of ages 18 years and older were eligible for inclusion if they had valid US social security numbers. The Cleveland Clinic Foundation Institutional Review Board approved the study. 
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Ambulatory BP recordings. Twenty-four hour ambulatory BP and heart rate monitoring were performed on Spacelabs 90207 (Spacelabs Medical, Redmond, WA). Monitors recorded heart rate, SBP, and diastolic BP readings every 15 min during the daytime and every 30 min overnight, for the 24-h period. Daytime (6 am-11 pm) and nighttime (11 pm-6 am) SBPs were defined prospectively. We calculated the dipping percentage as:
We prospectively defined non-dipping as a drop in mean nocturnal SBP of <10% as compared with mean daytime values (dipping percentage <10%). 7, 14 Endpoint. The only endpoint we used was all-cause mortality. All-cause mortality is the most unbiased endpoint for medical outcomes research, particularly in retrospective studies, because comorbid illnesses and ascertainment bias may affect the ascribed cause of death. 23, 24 The Social Security Death Index was used for determining the timing of death, 25 and was accessed on 31 October 2006.
Clinical information and laboratory data. Clinical information was obtained by a thorough standardized review of the written and electronic medical records. Patients were defined as having a history of hypertension if this diagnosis was listed in their medical history (generally based on office measurements), or if they were prescribed antihypertensive medications (whether or not they were taking them at the time of the BP monitoring). Glomerular filtration rate was calculated using the Modification of Diet in Renal Disease 4-variable equation. 26 Body mass index was calculated as (weight in kilograms)/(height in meters) 2 . Missing values of continuous variables were imputed at the median. We defined diabetes as the use of glucose-lowering medications or a fasting glucose level >125 mg/dl, if the information was available. Chronic obstructive pulmonary disease and asthma were defined by clinical diagnosis of these conditions or by the use of bronchodilator medications. Congestive heart failure, obstructive sleep apnea, hypertension, and coronary artery disease were defined on the basis of clinical diagnoses listed in the patients' medical records or upon disease-specific testing (such as cardiac catheterization) carried out on the patient, if the information was available. Medication usage, height, and weight were specifically ascertained at the time of the ambulatory BP recording.
Statistical analysis. The specific statistical analyses we employed were defined prospectively. We were concerned lest the number of events in our sample be too small to provide optimal statistical power to show a difference in the hazard of death, when the primary independent variable (diurnal BP variation) was dichotomized. We therefore decided to examine non-dipping as a continuous variable (dipping percentage), and to examine it as a categorical variable (dipping vs. non-dipping) only as a secondary analysis.
In order to test differences between proportions, we used the χ 2 test. t-Tests were used for comparing continuous data across groups. Multivariable logistic regression was used for calculating adjusted odds ratios associating non-dipping with non-timedependent variables. The log-rank test was used for testing the hypothesis that the risk of death for dippers differed from that for non-dippers. In order to calculate hazard ratios for death, we entered death as an outcome into Cox proportional-hazards regression, censoring data at 31 October 2006, for those patients who had not been entered into the Social Security Death Index prior to that date. For continuous variables, we expressed hazard ratios based on an increment (or decrement) in the variable across the interquartile range (25th to 75th percentile). We found no evidence of violation of the "proportional hazards" assumption when we tested for an interaction between duration of follow-up and dipping pattern in predicting death (P = 0.44). In order to determine which variables retained significant incremental predictive ability for death after adjustment for other predictors, significant univariate predictors of death were entered into a Cox proportional-hazards model, and backward stepwise selection was employed, using a threshold of P = 0.05 for leaving the model.
In view of the fact that many variables were associated with the main independent variable (diurnal BP variation), we carried out a separate analysis using a propensity-score method to adjust for confounding factors. In order to create a propensity score for each subject, we used dipping percentage as the dependent variable and included, in a non-parsimonious multiple regression model, all the baseline clinical variables available, including age (continuous), gender, race (white vs. non-white), body mass index (continuous), glomerular filtration rate (continuous), the presence or absence of diabetes, chronic obstructive pulmonary disease or asthma, coronary artery disease, congestive heart failure, whether the subject had ever smoked, presence or absence of obstructive sleep apnea, the use or non-use of any antihypertensive and of specific antihypertensives (β-blockers, angiotensin converting enzyme inhibitors or angiotensin receptor blockers, calcium blockers, any diuretics), and the use or non-use of a statin. The propensity model also included mean 24-h SBP, diastolic BP, and heart rate (each as a continuous variable) obtained from the ambulatory BP monitoring. The propensity score values were then converted into deciles reflecting the predicted dipping percentage on a scale of 1-10, and used as a continuous adjustor variable in the propensity-adjusted models. The low number of outcome events prevented the optimal use of propensity score decile as a categorical stratification variable. A second propensity score model was constructed using non-dipping as a dichotomous dependent variable in a non-parsimonious logistic regression model that employed the same independent variables, but because the output of this model was very similar to the initial model (r = 0.90), and because both models worked well in attenuating the relationship between dipping percentage (or non-dipping) and the other clinical variables, the output of the initial model was used for all propensity score adjustments, as Mean daytime SBP -Mean nighttime SBP Mean daytime SBP × 100%
articles Non-dipping Blood Pressure and All-cause Mortality per our prospectively defined statistical strategy. We did not use any other variables as adjustors in the propensity-score-adjusted models, because the propensity score was successful in eliminating all significant adjusted differences between dippers and non-dippers and all significant associations between dipping percentage and the other clinical variables. This is illustrated in Table 1 , in which all significant unadjusted differences between dippers and non-dippers became insignificant after propensity score adjustment. All P values are two-sided and we defined the threshold of significance at α = 0.05.
RESULTS
Associations between BP pattern and clinical variables
In total, 621 patients met the inclusion criteria. Of these, 261 were dippers, exhibiting a mean nocturnal drop in SBP of 15.0% from daytime values, while 360 were non-dippers, with a mean dipping percentage of 2.9%. Baseline characteristics of dippers and non-dippers are shown in Table 1 . Non-dippers tended to be older (mean age 63.3 vs. 58.6 years, P < 0.0001), were less likely to be white (79.2% vs. 85.4%, P < 0.05) and had higher prevalence rates of diabetes (13.9% vs. 6.5%, P < 0.005), diagnosed hypertension (80.1% vs. 65.9%, P < 0.0001), coronary artery disease (17.8% vs. 7.7%, P < 0.0005), and congestive heart failure (4.8% vs. 1.9%, P < 0.005). Non-dippers were also more likely to be current or former smokers (24.7% vs. 16.1%, P < 0.01), and had lower glomerular filtration rates (mean 75.1 vs. 82.1 ml/min/1.73 m 2 , P < 0.005). They were also more likely to be taking antihypertensive medication (P < 0.05 for all classes). Despite the high prevalence of cardiovascular risk factors in our cohort, only ~20% of the patients were taking statins, and this was not significantly related to dipping status. As recorded by ambulatory BP monitoring, the mean 24-h SBP was higher in non-dippers (140.5 vs. 132.0 mm Hg, P < 0.0001), but diastolic BP was only marginally higher (79.1 vs. 77.3 mm Hg, P < 0.05), and heart rate was not significantly different. Patients with a diagnosis of hypertension had a median 24-h SBP of 136 mm Hg (interquartile range 120-148) and a median diastolic BP of 77 mm Hg (interquartile range 70-85), thereby suggesting that in most patients with hypertension the BP was under acceptable control.
Predictors of death
Many of the clinical variables we measured were (statistically) significantly associated with death, as shown on Table 2 . Nondipping (defined as either a continuous variable or as a categorical variable, as shown in Figure 1 ) was a strong univariate Comorbid illnesses at baseline Diabetes mellitus (n (%)) Hypertension (n (%)) Coronary artery disease (n (%)) Obstructive sleep apnea (n (%)) History of smoking (n (%)) Obstructive pulmonary disease or asthma (n (%)) Congestive heart failure (n (%)) articles
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predictor of all-cause mortality (P < 0.0001). Other predictors of death included older age, hypertension, renal insufficiency, coronary artery disease, congestive heart failure, diabetes, chronic obstructive pulmonary disease or asthma, and smoking (P ≤ 0.01 for all). In a stepwise regression model, the predictors of all-cause mortality that remained significant included age, mean 24-h SBP, impaired diurnal BP variation, and low glomerular filtration rate. All of these predictors retained statistical significance (P < 0.05) when the propensity score was added to this Cox model as an independent variable. As shown in Table 3 , impaired diurnal BP variation, measured as either a continuous variable or a categorical variable, remained significantly associated with the hazard of death in all models, whether the co-variables were adjusted for using propensity-score methods (to account for all measured variables) or stepwise regression (to account for the other significant predictors of death). In all models, the strength of this association between non-dipping and mortality was moderately attenuated by statistical adjustment for the other clinical variables.
DISCUSSION
We present the first longitudinal data to show that non-dipping is associated with all-cause mortality. This relationship was strong and persisted after adjustment for measured confounding variables, including mean SBP and diastolic BP, diabetes, and renal impairment. However, multivariable adjustment substantially Table 1 were included in a nonparsimonious regression model to predict the percent decline in SBP at night; this predicted value was used as an adjustor variable. c Other variables included age, mean 24-h SBP, and glomerular filtration rate (P < 0.001 for all).
articles Non-dipping Blood Pressure and All-cause Mortality attenuated the relationship between non-dipping and mortality, thereby suggesting that improved measurement of confounding variables may have reduced the adjusted relationship between non-dipping and mortality even further. 27, 28 Nevertheless, we believe that the association between impaired diurnal BP variation and multiple cardiovascular risk factors-including diabetes, hypertension, chronic renal insufficiency, age, non-white race, coronary artery disease-and its strong relationship to all-cause mortality supports the theory that abnormal diurnal BP variation is a common pathological manifestation of a variety of cardiovascular risk factors. In keeping with this assertion, we note that autonomic imbalance is a feature of many cardiovascular risk factors-including renal insufficiency, diabetes, and congestive heart failure-and is probably an important mechanism underlying impaired diurnal BP variation. 17, 19, 29 We recognize that other types of vascular pathology, such as endothelial dysfunction, may also explain some of the relationship between non-dipping and other cardiovascular risk factors. 30, 31 But we suspect that diurnal variability in vascular reactivity or fluid homeostasis of any nature is likely to be driven, at least partly, by diurnal fluctuations in central stress axis activation. 32, 33 Although we cannot make therapeutic recommendations based on this study, we speculate that "treatments" for non-dipping should be directed at hypertension and associated cardiovascular risk factors, rather than at the BP pattern per se, or at increased sympathetic tone specifically. A few limitations of our study deserve mention. Because this was a retrospective study, longitudinal assessment of hypertension control and changes in antihypertensive therapy were beyond the scope of the investigation. Also, multiple assessments of ambulatory BP were not performed, thereby eliminating our ability to determine whether dipping status was stable over time and whether it was impacted by antihypertensive treatment. 34 Intra-individual variations in dipping status would tend to weaken our findings, by diluting the association between impaired diurnal BP variation and the other variables. An additional limitation of our study is that, with only 61 events (reported deaths), we did not have the statistical power to optimally evaluate the potential contribution of important clinical variables (such as coronary disease, heart failure, and diabetes) to mortality. Given the extent of existing research data implicating these diseases as important risk factors for death, we suspect that it was the inherent limited statistical power in our study that prevented these factors from showing statistical significance in stepwise regression. Perhaps the most important limitation of our study, however, is that we did not have a sufficient number of patients with measurements of certain cardiovascular risk factors-such as fasting lipid profiles, microalbuminuria, and high-sensitivity C-reactive protein-to optimally account for these variables in our statistical adjustments. However, this is a limitation of virtually all cardiovascular risk factor research, and we advocate a move away from the identification of so-called "independent" cardiovascular risk factors towards research that highlights how and why cardiovascular risk factors cluster in some individuals and the mechanisms by which non-traditional risk factors confer risk. 28 To this end, we believe that this study offers some mechanistic insights into the ubiquitous and important role that altered stress axis activation plays in vascular health and disease, and we suggest that the pathophysiology that underlies non-dipping may represent one of the common pathways by which traditional cardiovascular risk factors lead to death. Finally, it is worth noting that 58% of the patients in this cohort were non-dippers, in contrast to most study samples in which fewer than half of the patients are non-dippers. This may limit the application of our findings to healthier populations.
In summary, we have demonstrated that non-dipping is a risk factor for all-cause mortality, independent of mean 24-h BP load, and that non-dipping is a feature of a variety of other established cardiovascular risk factors, which may account for the strong association between non-dipping and mortality. We suggest that our findings are probably mediated through impaired nocturnal relaxation of stress axes, particularly the sympathetic nervous system, but further elucidation of the mechanisms responsible for impaired diurnal BP is warranted.
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